Cite
HARVARD Citation
Goldstein, D. et al. (2017). Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis. Oncologist. pp. 694-699. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goldstein, D. et al. (2017). Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis. Oncologist. pp. 694-699. [Online].